These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 15539405)

  • 21. The vitamin D receptor is not required for fetal mineral homeostasis or for the regulation of placental calcium transfer in mice.
    Kovacs CS; Woodland ML; Fudge NJ; Friel JK
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E133-44. PubMed ID: 15741244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer cell regulation by high-dose Vitamin D compounds in the absence of nuclear vitamin D receptor.
    Valrance ME; Welsh J
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):221-5. PubMed ID: 15225775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of five 19-nor-analogs of 1alpha,25(OH)2-Vitamin D3 with 20-cyclopropyl-modified side-chains: implications for ligand binding and calcemic properties.
    Olivera CJ; Bula CM; Bishop JE; Adorini L; Manchand P; Uskokovic MR; Norman AW
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):99-106. PubMed ID: 15225754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma membrane requirements for 1alpha,25(OH)2D3 dependent PKC signaling in chondrocytes and osteoblasts.
    Boyan BD; Wang L; Wong KL; Jo H; Schwartz Z
    Steroids; 2006 Apr; 71(4):286-90. PubMed ID: 16325216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway.
    Hughes PJ; Brown G
    J Cell Biochem; 2006 Jun; 98(3):590-617. PubMed ID: 16440327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
    Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
    Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1alpha,25-Dihydroxyvitamin D3-3beta-(2)-bromoacetate, an affinity labeling derivative of 1alpha,25-dihydroxyvitamin D3 displays strong antiproliferative and cytotoxic behavior in prostate cancer cells.
    Swamy N; Persons KS; Chen TC; Ray R
    J Cell Biochem; 2003 Aug; 89(5):909-16. PubMed ID: 12874825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of VDR-responsive gene signatures in breast cancer cells.
    Towsend K; Trevino V; Falciani F; Stewart PM; Hewison M; Campbell MJ
    Oncology; 2006; 71(1-2):111-23. PubMed ID: 17377416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation.
    Lopes N; Carvalho J; Durães C; Sousa B; Gomes M; Costa JL; Oliveira C; Paredes J; Schmitt F
    Anticancer Res; 2012 Jan; 32(1):249-57. PubMed ID: 22213313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D receptor ablation alters skin architecture and homeostasis of dendritic epidermal T cells.
    Meindl S; Rot A; Hoetzenecker W; Kato S; Cross HS; Elbe-Bürger A
    Br J Dermatol; 2005 Feb; 152(2):231-41. PubMed ID: 15727633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based design of a superagonist ligand for the vitamin D nuclear receptor.
    Hourai S; Rodrigues LC; Antony P; Reina-San-Martin B; Ciesielski F; Magnier BC; Schoonjans K; Mouriño A; Rochel N; Moras D
    Chem Biol; 2008 Apr; 15(4):383-92. PubMed ID: 18420145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
    Chen TC; Holick MF; Lokeshwar BL; Burnstein KL; Schwartz GG
    Recent Results Cancer Res; 2003; 164():273-88. PubMed ID: 12899529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1Alpha,25-dihydroxyvitamin D3 up-regulates P-glycoprotein via the vitamin D receptor and not farnesoid X receptor in both fxr(-/-) and fxr(+/+) mice and increased renal and brain efflux of digoxin in mice in vivo.
    Chow EC; Durk MR; Cummins CL; Pang KS
    J Pharmacol Exp Ther; 2011 Jun; 337(3):846-59. PubMed ID: 21421739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D regulates the phenotype of human breast cancer cells.
    Pendás-Franco N; González-Sancho JM; Suárez Y; Aguilera O; Steinmeyer A; Gamallo C; Berciano MT; Lafarga M; Muñoz A
    Differentiation; 2007 Mar; 75(3):193-207. PubMed ID: 17288543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
    Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
    Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D receptor modulates the neoplastic phenotype through antagonistic growth regulatory signals.
    Xu H; McCann M; Zhang Z; Posner GH; Bingham V; El-Tanani M; Campbell FC
    Mol Carcinog; 2009 Aug; 48(8):758-72. PubMed ID: 19184984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs.
    Takasu H; Sugita A; Uchiyama Y; Katagiri N; Okazaki M; Ogata E; Ikeda K
    J Clin Invest; 2006 Feb; 116(2):528-35. PubMed ID: 16424941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells.
    Fernandez-Garcia NI; Palmer HG; Garcia M; Gonzalez-Martin A; del Rio M; Barettino D; Volpert O; Muñoz A; Jimenez B
    Oncogene; 2005 Sep; 24(43):6533-44. PubMed ID: 16007183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings.
    Verstuyf A; Verlinden L; Van Baelen H; Sabbe K; D'Hallewyn C; De Clercq P; Vandewalle M; Bouillon R
    J Bone Miner Res; 1998 Apr; 13(4):549-58. PubMed ID: 9556055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.